11 July 2013
Clinical trials by foreign pharmaceutical companies in India have slowed down due to new government rules that complicate testing for new drugs.
India's government implemented rules in January that impose a new approval process for trials and compensation packages for patients who fall sick or die during testing.
The Health Ministry signed the laws after it found in a probe last year that new drugs in some cases were being tested on patients without informing them. The probe was ordered by the Supreme Court after a nonprofit group in the central state of Madhya Pradesh complained.